<DOC>
	<DOC>NCT01938872</DOC>
	<brief_summary>to evaluate the the effectiveness of paclitaxel-eluting balloon for below-the-knee angioplasty in terms of restenosis at 12 months</brief_summary>
	<brief_title>Evaluating the Effectiveness of Paclitaxel-eluting Balloons for Below-the-knee Angioplasty in Patients With Critical Limb Ischemia</brief_title>
	<detailed_description />
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>age&gt;18 years angiographic stenosis&gt;50% or occlusion of one belowknee vessel allergy to Paclitaxel contraindication for combined antiplatelet treatment life expectancy &lt;1 year hypersensitivity or contraindication to one of the study drugs lack of consent need for amputation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>critical limb ischemia</keyword>
	<keyword>drug-eluting balloon</keyword>
	<keyword>restenosis</keyword>
</DOC>